Profile
Xavier Avat, former Head of Corporate Development at Gilead Sciences, Inc., served as the SVP of Global Corporate Strategy & New Initiatives at Edwards Lifesciences Corp.
He also held the position of Vice President of Corporate Development at Santen Pharmaceutical Co., Ltd.
In 2022-2023, Avat worked as the Chief Business Officer at Capricor Therapeutics, Inc. Avat graduated from Ecole Polytechnique Universitaire de Lille and holds an MBA from École des Hautes Études Commerciales du Nord.
Former positions of Xavier Avat
| Companies | Position | End |
|---|---|---|
| CAPRICOR THERAPEUTICS, INC. | Corporate Officer/Principal | 01/04/2023 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | - |
| SANTEN PHARMACEUTICAL CO., LTD. | Corporate Officer/Principal | - |
| EDWARDS LIFESCIENCES CORPORATION | Corporate Officer/Principal | - |
Training of Xavier Avat
| École des Hautes Études Commerciales du Nord | Masters Business Admin |
| Ecole Polytechnique Universitaire de Lille | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| CAPRICOR THERAPEUTICS, INC. | Health Technology |
| EDWARDS LIFESCIENCES CORPORATION | Health Technology |
| SANTEN PHARMACEUTICAL CO., LTD. | Health Technology |
| GILEAD SCIENCES, INC. | Health Technology |
- Stock Market
- Insiders
- Xavier Avat
